Key facts
- Developer of a metabolic health assessment platform designed to support healthcare professionals in identifying at-risk individuals before traditional diagnostics.
- Maven Health’s last known valuation is $5.8M (Apr 2025).
- It has raised $570K; the latest was Seed Round ($410K) in Apr 2025.
- Notable investors include Venture Kick, Ecole Polytechnique Federale de Lausanne, S2S Ventures, DayOne Accelerator, Founderful Campus — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Maven Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Maven Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Maven Health
Developer of a metabolic health assessment platform designed to support healthcare professionals in identifying at-risk individuals before traditional diagnostics. The company uses saliva-based metabolite measurements analyzed through customized Nuclear Magnetic Resonance (NMR) spectrometry, enabling registered nutritionists and healthcare providers to assess metabolic health with minimal invasiveness, competitive cost, and early detection capabilities.
- Sector
- Healthcare
- HQ
- Zurich, Switzerland
- Founded
- 2022
- Employees
- 3
- Website
- mavenhealth.ch/en
- Ownership
- Privately Held (backing)
Maven Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.